With a market capitalization (market cap) of $2.3B — a measure of how much the company is worth — Alamar Biosciences, Inc. is the 2012th most valuable company in Healthcare as of August 12, 2026. Shares trade at $33.12, down +9.43% on the day.
of 2,600
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
As of August 12, 2026, Alamar Biosciences, Inc. (ALMR) is worth $2.3B — this is its market capitalization, the total value of all its outstanding shares.
Alamar Biosciences, Inc.’s market cap is $2.3B, which ranks it #2012 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Alamar Biosciences, Inc. (ALMR) shares trade at $33.12, down 9.43% on the day, as of August 12, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025